FDA Clears Early Sepsis Indicator from Beckman Coulter
Beckman’s Early Sepsis Indicator is a first-of-its-kind, hematology-based cellular biomarker for identifying patients with sepsis, or those at increased risk of developing sepsis.
Read More
Search Results for: hematology
Inside Track: Transforming Diagnostics
With an increasing US prevalence of vector-borne illnesses such as Lyme disease, there is a pressing need to improve clinical diagnostics.
Read More
Quality Control Media Help to Reduce Sepsis among Patients Requiring Platelet Transfusion
BD’s quality control media for platelet testing have been CE marked and cleared by FDA.
Read MoreRunning Samples
This is a companion article to the news story, “Beckman Coulter Updates Hematology Analyzer Recall.” In its updated recall letter for the DxH 600, DxH 800, and DxH 900 hematology analyzers, Beckman Coulter advises...
Read MoreRunning Samples
This is a companion article to the feature, “Beckman Coulter Updates Hematology Analyzer Recall.” In its updated recall letter for the DxH 600, DxH 800, and DxH 900 hematology analyzers, Beckman Coulter advises...
Read More